Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cβ1
暂无分享,去创建一个
[1] James M. Stone,et al. Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review , 2007, Journal of psychopharmacology.
[2] K. Jakobs,et al. Dynamic phospholipid signaling by G protein-coupled receptors. , 2007, Biochimica et biophysica acta.
[3] B. Turetsky,et al. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. , 2006, Schizophrenia bulletin.
[4] J. Gogos,et al. Modeling Madness in Mice: One Piece at a Time , 2006, Neuron.
[5] Gregory A. Miller,et al. Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia , 2006, Schizophrenia Research.
[6] S. Ryu,et al. Haloperidol induces calcium ion influx via L-type calcium channels in hippocampal HN33 cells and renders the neurons more susceptible to oxidative stress. , 2006, Molecules and cells.
[7] T. Miyakawa,et al. Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? , 2006, Biological Psychiatry.
[8] G. Robertson,et al. Schizophrenia: an integrative approach to modelling a complex disorder. , 2006, Journal of psychiatry & neuroscience : JPN.
[9] M. Covic,et al. Arginine Methylation Regulates DNA Polymerase β , 2006 .
[10] A. Epstein,et al. Knocking‐down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning , 2006, Journal of neurochemistry.
[11] J. Gogos,et al. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. , 2006, Trends in pharmacological sciences.
[12] I. Gottesman,et al. Psychiatric endophenotypes and the development of valid animal models , 2006, Genes, brain, and behavior.
[13] E. Kandel,et al. Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.
[14] Hee-Sup Shin,et al. Genetic dissection of theta rhythm heterogeneity in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Naoshi Kaneko,et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. , 2005, American journal of human genetics.
[16] R. Malenka,et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Fradley,et al. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating , 2005, Behavioural Brain Research.
[18] M. Suaud-Chagny,et al. Dopaminergic transmission in STOP null mice , 2005, Journal of neurochemistry.
[19] Xu-Feng Huang,et al. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[20] J. Crawley. Designing mouse behavioral tasks relevant to autistic-like behaviors. , 2004, Mental retardation and developmental disabilities research reviews.
[21] J. Feldon,et al. Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment , 2004, Psychopharmacology.
[22] R. Paylor,et al. Expanded characterization of the social interaction abnormalities in mice lacking Dvl1 , 2004, Genes, Brain and Behavior.
[23] Hongkui Zeng,et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Paul Antoine Salin,et al. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. , 2002, Genes & development.
[25] A. Martelli,et al. Molecular characterization of the human PLC β1 gene , 2002 .
[26] T. Sotnikova,et al. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] Hongkui Zeng,et al. Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.
[28] A Carlsson,et al. A Paradigm Shift in Brain Research , 2001, Science.
[29] R. Gainetdinov,et al. Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.
[30] R. Wong,et al. Group I Metabotropic Glutamate Receptors Elicit Epileptiform Discharges in the Hippocampus through PLCβ1 Signaling , 2001, Journal of Neuroscience.
[31] Noboru Kitamura,et al. Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[32] D. Kupfer,et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria , 2001, Biological Psychiatry.
[33] R. Dias,et al. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching‐ and matching‐to‐place in the T‐maze in the rat: differential involvement of the prelimbic–infralimbic and anterior cingulate cortices in providing behavioural flexibility , 2000, The European journal of neuroscience.
[34] David A Lewis,et al. Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.
[35] Y. Smith,et al. Anatomy of the dopamine system in the basal ganglia , 2000, Trends in Neurosciences.
[36] A. Hamm,et al. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients , 2000, Biological Psychiatry.
[37] O. Shirakawa,et al. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia , 1999, Biological Psychiatry.
[38] Marc G Caron,et al. Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.
[39] M. Laruelle,et al. Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.
[40] E D Levin,et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.
[41] Masahiko Watanabe,et al. Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cβ in mouse brain , 1998, The European journal of neuroscience.
[42] S. Ryu,et al. Phospholipase C isozymes selectively couple to specific neurotransmitter receptors , 1997, Nature.
[43] Richard Paylor,et al. Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.
[44] S. Rhee,et al. Regulation of Phosphoinositide-specific Phospholipase C Isozymes* , 1997, The Journal of Biological Chemistry.
[45] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Andreasen,et al. Symptoms, signs, and diagnosis of schizophrenia , 1995, The Lancet.
[47] A. A. Spector,et al. Membrane lipid composition and cellular function. , 1985, Journal of lipid research.
[48] M. Festing,et al. Whisker trimming in mice , 1981, Laboratory animals.
[49] A. Oliverio,et al. Dominance behavior: A phylogenetic analysis in the mouse , 1975, Physiology & Behavior.
[50] S. Iversen,et al. The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.
[51] C. W. Schneider,et al. Effects of Hallucinogenic and other Drugs on the Nest-building Behaviour of Mice , 1970, Nature.
[52] B. Garner,et al. Importance of animal models in schizophrenia research. , 2005, The Australian and New Zealand journal of psychiatry.
[53] A. Martelli,et al. Molecular characterization of the human PLC beta1 gene. , 2002, Biochimica et biophysica acta.
[54] D. Braff,et al. 51 ENDOPHENOTYPES IN STUDIES OF THE GENETICS OF SCHIZOPHRENIA , 2002 .
[55] T. Goldberg,et al. Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.
[56] G. Pascal,et al. Essentiality of omega 3 fatty acids for brain structure and function. , 1991, World review of nutrition and dietetics.
[57] G. Pascal,et al. Essentiality of ω3 Fatty Acids for Brain Structure and Function1 , 1991 .